Welcome visitor Log In - or - Register
0 items /
View Cart
Check Out
four ways
Quick Search:
IACS-13909 is a potent and specific allosteric inhibitor of SHP2, suppressing the signaling of RTK/MAPK pathway. IACS-13909 potently impedes the proliferation of tumors with a broad spectrum of RTKs as the oncogenic driver. Importantly, in NSCLC models with acquired resistance to Osimertinib, IACS-13909 administered as a single agent or in combination with Osimertinib potently reduces tumor cell proliferation in vitro and in vivo, which provide preclinical evidence for using a SHP2 inhibitor as a therapeutic strategy in acquired EGFR inhibitor-resistant NSCLC (ref 1).
Catalog NO: CT-IACS909
CAS NO: 2160546-07-4
Mol. Formula: C17H18Cl2N6
MW: 377.3
** in vivo Quality Materiaal . >99.5% by HPLC. Bulk Stock, Prompt